A randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: Early stopping for lack of efficacy

Clinical Trials

Volumn 9, Issue 2, 2012, Pages 188-197

  Tilley, Barbara C ^a   Mainous, Arch G ^b   Elm, Jordan J ^b   Pickelsimer, Elisabeth ^b   Soderstrom, Lea H ^b   Ford, Marvella E ^b,c   Diaz, Vanessa A ^b   Siminoff, Laura A ^d   Burau, Keith ^a   Smith, Daniel W ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE;

ARTICLE; CLINICAL PRACTICE; DISEASE SEVERITY; DRUG EFFICACY; ETHNIC DIFFERENCE; GROUPS BY AGE; HUMAN; INTERVIEW; MOTOR DYSFUNCTION; OUTCOME ASSESSMENT; PARKINSON DISEASE; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CLINICAL TRIALS AS TOPIC; HUMANS; INTERVIEWS AS TOPIC; MIDDLE AGED; PARKINSON DISEASE; PATIENT SELECTION; RANDOM ALLOCATION; SAMPLE SIZE; UNITED STATES;

EID: 84861801585     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774512436881     Document Type: Article

References (28)

1. Taylor JS, Ellis GR. Racial differences in responses to drug treatment: Implications for pharmacotherapy of heart failure. Am J Cardiovasc Drugs. 2002 ; 2: 389-99
2. Bjornsson TD, Wagner JA, Donahue SR, et al. A review and assessment of potential sources of ethnic differences in drug responsiveness. J Clin Pharmacol. 2003 ; 43: 943-67
3. Curry L, Jackson J The Science of Inclusion: Recruiting and Retaining Racial and Ethnic Elders in Health Research. Curry L Jackson J, ed. Washington, DC: The Gerontological Society of America ; 2003: 1-7.
4. Levkoff S, Sanchez H. Lessons learned about minority recruitment and retention from the Centers on Minority Aging and Health Promotion. Gerontologist. 2003 ; 43 (1). 18-26
5. Bluestein J, Weiss LJ. Visits to specialists under medicare: Socioeconomic advantage and access to care. J Health Care Poor U. 1998 ; 9: 153-69
6. A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology. 2006 ; 66: 664-71
7. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson's disease. Neurology. 2007 ; 68: 20-8
8. Schneider MG, Swearingen CJ, Schulman L, et al. Minority enrollment in Parkinson's disease clinical trials. Parkinsonism Relat D. 2009 ; 15: 258-62
9. de Lau LM, Breteler MB. Epidemiology of Parkinson's disease. Lancet Neurol. 2006 ; 5: 525-35
10. Jenkins V, Fallowfield L. Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer. 2000 ; 82: 1783-88
11. Daugherty C, Ratain MJ, Grochowski E, et al. Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol. 1995 ; 13: 1062-72
12. Albrecht TL, Eggly SS, Gleason ME, et al. Influence of clinical communication on patients' decision making on participation in clinical trials. J Clin Oncol. 2008 ; 26: 2666-73
13. Mainous AG, Smith DW, Geesey ME, et al. Development of a measure to assess patient trust in medical researchers. Ann Fam Med. 2004 ; 4: 247-52
14. Mainous AG, Smith DW, Geesey ME, et al. Factors influencing physician referrals of patients to clinical trials. J Natl Med Assoc. 2008 ; 100: 1298-303
15. McCaskill-Stevens W, Pinto H, Marcus AC, et al. Recruiting minority cancer patients into cancer clinical trials: A pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. J Clin Oncol. 1999 ; 17: 1029-39
16. Royal CD, Baffoe-Bonnie A, Kittles R, et al. Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) Study. Ann Epidemiol. 2000 ; 10 (suppl 8). S68 - S77
17. Siminoff LA, Step MM. A communication model of shared decision making: Accounting for cancer treatment decisions. Health Psychol. 2005 ; 24 (suppl 4). S99 - S105
18. Hudson SV, Momperousse D, Leventhal H. Physician perspectives on cancer clinical trials and barriers to minority recruitment. Cancer Ctl. 2005 ; 12 (suppl 2). 93-6
19. Shavers VL, Lynch CF, Burmeister LF. Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol. 2002 ; 12: 248-56
20. Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review. Cancer. 2008 ; 112: 228-42
21. NINDS Clinical Research Collaboration. Available at: http://www.ninds. nih.gov/research/clinical-research/crc.htm (accessed 3 Feb 2012).
22. Lan KKG, Wittes J. The B-value: A tool for monitoring data. Biometrics. 1988 ; 44: 579-85
23. Lynch GF, Gorelick PB, Raman R, Leurgans S. A pilot survey of African-American physician perceptions about clinical trials. J Natl Med Assoc. 2001 ; 93 (suppl 12). 8S - 13S
24. Forsetlund L, Bjørndal A, Rashidian A, et al. Continuing education meetings and workshops: Effects on professional practice and health care outcomes. Cochrane Database of Syst Rev. 2009 ; 2 :
25. Kornblith AB, Kemeny M, Peterson BL, et al. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer. 2002 ; 95: 989-96
26. Bain LJ. Crossroads in clinical trials. NeuroRx. 2005 ; 2: 525-8
27. Powell JH, Fleming Y, Walker-McGill CL, et al. The Project IMPACT experience to date: Increasing minority participation and awareness of clinical trials. J Natl Med Assoc. 2008 ; 100: 178-87
28. Akbari A, Mayhew A, Al-Alawi MA, et al. Interventions to improve outpatient referrals from primary care to secondary care. Cochrane DB Syst Rev. 2008 ; 4 :